This is the path Unitio takes to transform health, care and costs for everyone affected by chronic and acute medical needs.  Our innovative model unites patients, families, clinicians, researchers and industry to accelerate innovation, discovery and the delivery of new therapies.


Proprietary Technology

Unitio’s Community Application for Research and Engagement™ (CARE) platform is a proprietary real-world patient engagement platform designed to enable peer-to-peer support for people touched by disease while providing them with the opportunity to offer insights and engage in research opportunities.

Proven Expertise

Unitio has proven expertise in building, recruiting and retaining an engaged patient community that drives observational research and allows people touched by disease an opportunity to form connections with others—all to improve outcomes, speed treatment and improve quality of life.


Unitio is proud to showcase our programs—disease groups who are driving change and creating impact through connected communities working together for improved outcomes.


  • lls-logo

Unitio and The Leukemia & Lymphoma Society Partner to Create Online Patient-Caregiver Community

Patient engagement platform will provide support and empowerment while advancing blood cancer research BOSTON, November 2, 2015 – Unitio, Inc., a Boston based nonprofit organization and The Leukemia & Lymphoma Society (LLS) today announced a [...]

  • Locemia_Nasal-Glucagon-in-Hand

Lilly plans to take Locemia Solution’s needle-free glucagon to market

How T1D Exchange and its patient communities played a role in advancing intranasal glucagon T1D Exchange congratulates two of our member companies, Lilly and Locemia Solutions. Lilly acquired Phase III Intranasal Glucagon from Locemia Solutions. [...]

  • new-hire

T1D Exchange Adds New Talent to Accelerate Advances in Patient Care, Expand Impact in Type 1 Diabetes

Noted experts in molecular biology, healthcare quality, patient advocacy join the type 1 diabetes program of Unitio Boston, September 17, 2015 – T1D Exchange today announced that Wendy Wolf, Ph.D., Kenneth Scheer, C.P.H.Q., and former [...]

More News >